Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 12,664 shares at $34.10 ($432K) on 2018-08-30, disclosed to the SEC on 2018-09-04.
Open-market sale of $432k CRY by VP, Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.10 | 6,332 | $216K | 50.0% |
| 2 | $34.10 | 6,332 | $216K | 50.0% |
| Total | $34.10 avg | 12,664 | $432K | 100% |
| Filing → |
| CRY | SELL | 2019-06-03 | $57K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |
| CRY | SELL | 2016-02-23 | $155K | — | Filing → |